Agilent | A - Gross Profit On Sales

Stock Price
130.42
Daily Change
0.78 0.60%
Monthly
-11.77%
Yearly
-10.19%
Q1 Forecast
129.73

Agilent reported $990M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Agilent USD 990M 102M Sep/2025
Align Technology USD 683.59M 44.39M Dec/2025
Bio Techne USD 191.28M 3.16M Dec/2025
Bio-Rad Laboratories USD 345.3M 34.7M Jun/2025
Bruker USD 379.4M 21.5M Sep/2025
Charles River Laboratories USD 311.39M 6.77M Sep/2025
Danaher USD 3.97B 443M Dec/2025
Dentsply International USD 441M 49M Sep/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
Exact Sciences USD 583.93M 21.48M Sep/2025
Henry Schein USD 1.03B 74M Sep/2025
Hologic USD 586.4M 2.9M Dec/2025
Illumina USD 759M 26M Dec/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Laboratory Of America USD 1.03B 21.1M Sep/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 143.8M 8M Sep/2025
Quest Diagnostics USD 910M 6M Sep/2025
Quidel USD -733M 1.01B Sep/2025
Repligen USD 100.52M 9.37M Sep/2025
Revvity USD 374.6M 17.95M Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Waters USD 459.99M 21.97M Sep/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025